Design
Using an assessor-blind, parallel randomized controlled trial design, participants were recruited from 3 phase-2 hospital-based cardiac rehabilitation programs in Canberra, Australia, between January 2020 and December 2021. The study duration for each participant was 12 months (Flow of participants through the trial. ED: emergency department.